News | June 07, 2012

GE Healthcare Completes Acquisition of XPRO, a Medical Device Company in Brazil

A decision to foster a broader solution for emerging markets that will deliver complementary value image guidance products for minimally invasive procedures

June 7, 2012 — GE Healthcare announced the acquisition of XPRO, a Brazilian Interventional X-ray equipment manufacturer company with over 15 years of experience and with more than 120 systems installed at private customer sites. Combining XPRO’s Interventional X-Ray product capabilities with GE Healthcare’s complementary imaging technology and global distribution presence, this acquisition brings a significant enhancement of offerings in Brazil while creating a broader platform that will address access and quality challenges in emerging interventional X-ray segments. Terms of this transaction were not disclosed.

“We are very excited to welcome XPRO to GE. XPRO is a company with strong talent and capability and is well known in Brazil for delivering product and services, with both quality and value. This acquisition is very complementary to our existing product portfolio and helps to enhance a set of products that allow our global customers—particularly those in emerging markets—to build minimally invasive (MIS) capability, increase patients access to MIS, while also reducing costs," said Hooman Hakami, president & CEO, GE Healthcare -Detection & Guidance Solutions (DGS).

XPRO will be part of GE Healthcare's Detection & Guidance Solutions (DGS) business. DGS is a $2 billion global business, made up of 8 separate business segments, currently employing more than 1,700 employees. The DGS business distributes products and services in all geographies, and has engineering and manufacturing capability in the United States, France, Hungary, India and China. XPRO will expand DGS' engineering and manufacturing presence in Brazil, and add an additional 132 employees.

“At GE Healthcare we are committed to developing more targeted technologies that will help provide more access to quality healthcare, at a lower cost. The combined capabilities of GE and XPRO are a perfect example of this. This acquisition not only reinforces our commitment to growing our footprint in important countries like Brazil, but it also shows how we continue to take strong local capability —like those that exist at XPRO —combine them with our complementary imaging capabilities and global reach, and use this combination to help address healthcare challenges around the world," commented Rogério Patrus, president and CEO for GE Healthcare Latin America.

Benefiting from an excellent quality and customer service reputation, XPRO, with an installed base of more than 120 systems (analog and digital), currently supports local Brazilian private customers including hospitals and clinics, allowing clinicians to equip themselves with enhanced-guidance, economically-viable products.

“GE Healthcare Detection & Guidance Solutions and XPRO are highly complementary. Our value products have been strategically developed with our local customers needs in mind and GE is broadly recognized for its capabilities in R&D and distribution. With GE Healthcare’s proven track record in China and India for improving access to new technologies, we are confident that our combined know-how will reinforce our offering and positioning not only in Brazil but also in other emerging countries globally,” said Sandro Moraes, president, XPRO.

According to Reinaldo Garcia, president and CEO for GE Latin America, "XPRO’s acquisition fits into GE´s strategy of establishing presence in Latin America, and certainly in Brazil, one of the largest economies in the world. It continues to increase our footprint and capabilities, adding to the many development and production sites as well as the 20,000 people we have in the region. We are particularly excited about making this already important healthcare technology company a very significant base for our product development and exports from Brazil to the world.”

For more information: www.gehealthcare.com

Related Content

HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | Computed Tomography (CT) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
Post-Mortem CT Angiography Illuminates Causes of Death
News | CT Angiography (CTA) | June 25, 2018
Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-...
High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR
Technology | Angiography | May 22, 2018
Pie Medical Imaging announced that clinical data on its CAAS vFFR (Cardiovascular Angiographic Analysis Systems for...
360 Photos | Angiography | May 03, 2018
A 360 degree view of the newest cath lab at...
Guideline updates and clinical research highlight the need for improved understanding of gender differences by clinicians and patients
Feature | Women's Health | May 03, 2018 | By Jeff Zagoudis
Clinical research has revealed men and women often have different presentations for cardiovascular disease (CVD).
GE's OEC Elite CFD

GE's OEC Elite CFD

Feature | Mobile C-Arms | April 18, 2018 | Jeff Zagoudis
The market for mobile C-arm techn...
Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Radiology Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
Videos | RSNA 2017 | December 20, 2017
ITN and DAIC Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies on the
Philips Azurion Platform Improves Clinical Workflow and Staff Experience Benefits
News | Angiography | December 04, 2017
Philips recently announced the results of a comprehensive, independent, two-year study demonstrating the clinical...
Overlay Init